Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;36(11):108335.
doi: 10.1016/j.jdiacomp.2022.108335. Epub 2022 Oct 10.

Advances of neurovascular protective potential of 3-N-butylphthalide and its derivatives in diabetic related diseases

Affiliations
Review

Advances of neurovascular protective potential of 3-N-butylphthalide and its derivatives in diabetic related diseases

Shu-Wen Tan et al. J Diabetes Complications. 2022 Nov.

Abstract

3-N-butylphthalide (NBP) is a component isolated from seeds of Chinese celery, and it was firstly approved for the treatment of ischemic stroke. With the gradual in-depth understanding of its pharmacological action, it was found that it may have potential effects on treating diabetes and its complications. This review aims to illustrate the researches on the properties of NBP and its therapeutic efficacy in diabetic related diseases. This review will discuss the results of experiments in vitro and in vivo to make progress in understanding the beneficial effects of NBP and its derivatives on diabetic complications including diabetic vascular diseases, diabetic peripheral neuropathy, diabetic brain related diseases and diabetic cataract. We will also demonstrate NBP's numerous molecular targets and interactions with multiple cellular signaling pathways such as oxidative stress, inflammatory responses, apoptosis and autophagy. NBP is proved to be a potential therapeutic approach for treating diabetic complications.

Keywords: Butylphthalide; Diabetic cataract; Diabetic cognitive deficits; Diabetic vascular complication.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential interest.

Publication types

MeSH terms